When doctors treat patients with mixed-grade glioma, they often need to know exactly what kind of tumors they are dealing with. This new analysis looked at data from over 25,000 patients across 191 different studies to find clear patterns in these tumor types.
The results show that about 57% of tumors in mixed groups were low-grade gliomas. However, the numbers changed significantly depending on the setting. For example, patients in randomized controlled trials were much more likely to have low-grade tumors, with a rate of 93%. In contrast, those in surgery-only groups had a lower rate of 46%.
While these findings provide a helpful benchmark for doctors to use when planning treatments and designing future studies, the data comes from a very diverse set of sources. Because the original studies were so different from one another, the results should be used as a guide for understanding population trends rather than a specific prediction for any individual patient.
